足部感染对慢性肢体威胁性缺血患者腹股沟下旁路移植结局的影响
单中心回顾性队列研究分析454例腹股沟下旁路移植手术,比较伴或不伴足部感染患者的结局。足部感染是重大截肢和延长住院时间的独立预测因素,但不影响死亡率、伤口愈合时间或再入院。足部感染在糖尿病患者中更常见。
要点
- 足部感染是重大截肢的独立预测因素(HR 2.14,95%CI 1.42-3.22,P<.001)。
- 足部感染患者平均住院时间较无感染患者延长1.54天(P=.001)。
- 足部感染与死亡率、伤口愈合时间及再入院无显著关联。
核心结论
- 在因肢体威胁性缺血需行腹股沟下旁路移植的患者中,感染在糖尿病患者中更常见,且是重大截肢和延长住院时间的显著预测因素。
- 感染不能预测死亡率、伤口愈合时间或再入院。
- 这些发现支持将感染纳入慢性肢体威胁性缺血患者的风险分层方案,正如血管外科学会伤口、缺血和足部感染(WIfI)分类系统所推荐,因其对保肢有不良影响。
研究设计与样本
- 单中心回顾性队列研究,纳入因慢性肢体威胁性缺血行腹股沟下旁路移植的患者,共分析454例腹股沟下旁路移植手术。
- 研究终点包括长期死亡率、45天再入院、术后住院时间、重大截肢和伤口愈合时间,采用多变量Cox、logistic和稳健回归建模。
主要发现
- 足部感染对死亡率无影响(HR 0.78,P=.243);长期死亡率的显著预测因素包括年龄增加、低白蛋白血症和充血性心力衰竭,术前使用氯吡格雷具有保护作用。
- 足部感染是重大截肢的独立预测因素(HR 2.14,95%CI 1.42-3.22,P<.001);使用静脉导管、年龄增加和体重指数增加具有保护作用。
- 足部感染是延长住院时间的独立预测因素(感染患者较无感染患者平均住院时间延长1.54天,P=.001);其他独立预测因素包括术中失血和再次手术,术前持续使用阿司匹林、基线肾功能正常和白蛋白水平正常与住院时间缩短相关。
- 再入院受再次手术影响(OR 2.51,P<.001),但不受足部感染影响(OR 1.21,P=.349)。
- 糖尿病患者伤口愈合时间延长呈强趋势(HR 1.58,P=.05),但足部感染患者无此趋势(OR 0.74,P=.36)。
关键数值与推荐
- 足部感染与重大截肢独立相关:HR 2.14(95%CI 1.42-3.22,P<.001)。
- 足部感染与死亡率无显著关联:HR 0.78(P=.243)。
- 足部感染患者平均住院时间较无感染患者延长1.54天(P=.001)。
- 再入院与足部感染无显著关联:OR 1.21(P=.349)。
- 糖尿病患者伤口愈合时间延长呈强趋势:HR 1.58(P=.05);足部感染患者无显著关联:OR 0.74(P=.36)。
临床怎么用
- 原文结论支持将感染纳入慢性肢体威胁性缺血患者的风险分层方案,正如血管外科学会WIfI分类系统所推荐,因其对保肢有不良影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite advances in endovascular therapy, infrainguinal bypass continues to play a major role in achieving limb salvage. In this study, we sought to compare outcomes of infrainguinal bypass in patients with limb-threatening ischemia who presented with or without foot infection. METHODS: We conducted a retrospective cohort study of patients who underwent infrainguinal bypass for chronic limb-threatening ischemia at a single institution. End points of interest included long-term mortality, 45-day readmission, postoperative length of stay (LOS), major amputation, and time to wound healing. Multivariable Cox, logistic, and robust regressions were used to model time to event outcomes, readmission rates, and LOS. RESULTS: There were 454 infrainguinal bypass procedures analyzed. Demographics and baseline characteristics were similar, except congestive heart failure and diabetes were more common in the infection group. Presence of foot infection had no impact on mortality (hazard ratio [HR], 0.78; P = .243). Significant predictors of long-term mortality included increasing age, hypoalbuminemia, and congestive heart failure; preoperative use of clopidogrel was protective. Presence of foot infection was an independent predictor of major amputation. In the multiple regression model, the presence of foot infection was independently associated with amputation rate (HR, 2.14; 95% confidence interval, 1.42-3.22; P < .001); use of venous conduit and increasing age and body mass index were protective. Foot infection was an independent predictor of prolonged LOS (mean LOS was 1.54 days longer in patients with vs those without infection; P = .001). Other independent predictors of prolonged LOS included intraoperative blood loss and reoperation; history of continuous preoperative aspirin use and normal baseline renal function and albumin levels were associated with decreased LOS. Readmission was influenced by reoperation (odds ratio [OR], 2.51; P < .001) but not by presence of foot infection (OR, 1.21; P = .349). There was a strong trend for prolonged wound healing time in patients with diabetes (HR, 1.58; P = .05) but not in those with foot infection (OR, 0.74; P = .36). CONCLUSIONS: Among patients requiring infrainguinal bypass for limb-threatening ischemia, infection was more common in patients with diabetes and was a significant predictor of major amputation and prolonged LOS. Infection was not predictive of mortality, wound healing time, or readmission. These findings lend support to the inclusion of infection in risk stratification schemes for patients with chronic limb-threatening ischemia, as recommended in the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system, because of its adverse impacts on limb salvage.
引用
- Mayor JM, Valentin W, Sharath S, et al. The impact of foot infection on infrainguinal bypass outcomes in patients with chronic limb-threatening ischemia. J Vasc Surg. 2018. PMID: 30064844. doi:10.1016/j.jvs.2018.04.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。